Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effect of Iron Overload on Expression of PD-1 on Surface of T Lymphocyte in Mice].

Zhongguo shi yan xue ye xue za zhi·2025
Same author

[Expression and Significance of PD-1 and ICOS in Patients with Primary Immune Thrombocytopenia].

Zhongguo shi yan xue ye xue za zhi·2022
Same author

[Inhibitory Effect of Ascorbic Acid on Myelodysplastic Syndrome Cells and Its Mechanism].

Zhongguo shi yan xue ye xue za zhi·2021
Same author

[Research Progress on Pathogenesis of Congenital Pure Red Cell Aplasia---Review].

Zhongguo shi yan xue ye xue za zhi·2021
Same author

[Expression and Significance of IL-9 and IL-6 in Patients with BCR-ABL- MPN].

Zhongguo shi yan xue ye xue za zhi·2020
Same author

Advances in the role of helper T cells in autoimmune diseases.

Chinese medical journal·2020

Related Experiment Video

Updated: May 19, 2026

A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro
09:01

A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro

Published on: August 22, 2025

Research progress on the red cell diseases in China.

Lan-Zhu Yue1, Zong-Hong Shao

  • 1Department of Hematology, General Hospital of Tianjin Medical University, Tianjin 300052, China.

Chinese Medical Journal
|August 31, 2012
PubMed
Summary

Chinese hematologists have advanced the study of red cell diseases, particularly bone marrow failure syndromes. Research has improved understanding of pathogenesis, diagnosis, and treatment for conditions like aplastic anemia and myelodysplastic syndrome.

More Related Videos

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

Related Experiment Videos

Last Updated: May 19, 2026

A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro
09:01

A Quantitative Assessment of the Phagocytosis of Allogeneic and Xenogeneic Erythrocytes by Rat Macrophages In Vitro

Published on: August 22, 2025

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
05:58

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes

Published on: March 22, 2022

Area of Science:

  • Hematology
  • Internal Medicine
  • Oncology

Background:

  • Significant advancements in understanding red cell diseases in China.
  • Focus on bone marrow failure syndromes, including immuno-related pancytopenia, aplastic anemia, myelodysplastic syndrome, and paroxysmal nocturnal hemoglobinuria.

Purpose of the Study:

  • To summarize recent progress in the study of red cell diseases in China.
  • To highlight improvements in pathogenesis, diagnosis, and therapy.

Main Methods:

  • Extensive laboratory experiments.
  • Comprehensive clinical research conducted by Chinese hematologists.

Main Results:

  • Clearer understanding of the pathogenesis of various red cell diseases.
  • Development of more rational diagnostic methods.
  • Establishment of more effective therapeutic strategies.

Conclusions:

  • Recent research has significantly improved the management of red cell diseases in China.
  • Continued investigation promises further breakthroughs in hematology.